Novant Health has named Mark J. King its vice president of research and innovation, effective March 11.
King joins Novant Health from the Winston-Salem, N.C.-based health system's neighbor, Atrium Health. King serves as Atrium Health's assistant vice president of research administration, where he oversees clinical trials and research operations. He will continue in that role until March.
King previously led development of oncology clinical trials as assistant vice president for the clinical trials office at Atrium Health's Levine Cancer Institute.
At Novant Health, King will work with physician leaders across the 15-hospital system to improve patient access to clinical trials, according to a news release. He will work side-by-side with Dr. Steven Limentani, Novant Health's senior vice president of oncology, to expand the health system's clinical research portfolio and develop relationships with pharmaceutical companies and device manufacturers, as well as academic research centers.
Another component of King's new role will involve helping Novant Health apply emerging technologies, such as artificial intelligence, to clinical research efforts.
King will report to Dr. Eric Eskioglu, executive vice president and chief medical officer of Novant Health.
"Mark has over 15 years of experience in furthering research and development through clinical trials with medical and healthcare systems," Eskioglu said in a news release. "His depth of knowledge will be valuable in helping Novant Health continue to grow in the remarkable care we provide to our patients with expanded treatment options through advanced clinical research."